EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Platycodin D Attenuates Lipopolysaccharide‐Induced Acute Lung Injury by Modulating CD14 ‐Associated Inflammatory Signaling and Macrophage Phenotypic Responses

Lianting Liao iD, Lina Liu, Xianmin Zou, Pengfei Shen, Jinlong Zhao, Junhao Wang, Yufang Shen, Linyu Xiao, Renyikun Yuan iD, Hongwei Gao iD

Phytotherapy Research · 16.11.2026

DOI: 10.1002/ptr.70523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 16.11.2026. Verfasst von Lianting Liao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Innovative Drugs for Traditional Chinese Medicine and Zhuang & Yao Medicine, Ministry of Education, Guangxi University…. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangxi Distinguished Youth Science Foundation Project, Project of Guangxi Young Qihuang Scholar, Young Elite Scientists Sponsorship Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) is characterized by excessive pulmonary inflammation and lacks effective targeted pharmacotherapies. This study investigated the protective effects of Platycodin D (PLD) in lipopolysaccharide (LPS)‐induced ALI and explored the involvement of CD14‐associated inflammatory signaling and macrophage phenotypic regulation. Male C57BL/6 mice were challenged with intratracheal LPS and subsequently treated with PLD by inhalation (5 and 10 mg/kg) or intravenous injection (1 and 2 mg/kg), with dexamethasone (5 mg/kg, i.p.) as the positive control. PLD alleviated histopathological lung injury, reduced the lung index, pulmonary MPO levels, neutrophil infiltration, and pro‐inflammatory cytokines, and modulated macrophage‐associated inflammatory phenotypes. RNA‐seq analysis identified prominent regulation of NF‐κB and NOD‐like receptor signaling. Molecular docking, cellular co‐localization, CETSA, and DARTS analysis provided complementary evidence consistent with a possible interaction involving CD14. PLD suppressed TLR4/MyD88/NF‐κB signaling and downstream NLRP3 inflammasome‐associated responses in both lung tissue and macrophage models. In macrophages, PLD reduced M1‐associated markers and increased M2‐associated markers. CD14 knockdown altered these inflammatory and polarization responses, supporting a functional contribution of CD14, although PLD retained regulatory effects on several downstream markers after CD14 silencing. Collectively, these findings indicate that PLD attenuates LPS‐induced ALI through modulation of CD14‐associated inflammatory signaling and macrophage phenotypic regulation. The efficacy observed following both nebulized and intravenous administration provides a basis for further pharmacokinetic and translational evaluation of PLD.

Schlagwörter

Stichwörter der Autor:innen

NF‐κBNLRP3 inflammasomePlatycodin DTLR4acute lung injurymacrophage polarization

Autor:innen und Institutionen

  • Engineering Research Center of Innovative Drugs for Traditional Chinese Medicine and Zhuang & Yao Medicine, Ministry of Education, Guangxi University of Chinese Medicine, Nanning, China.
  • Institute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning, China.
  • College of Basic Medicine, Guangxi University of Chinese Medicine, Nanning, China.
  • Guangxi-ASEAN Institute of Natural Medicines, Nanning, China.

ORCID-Profile: Lianting Liao, Renyikun Yuan, Hongwei Gao

Förderung

  • Guangxi Distinguished Youth Science Foundation Project
  • Project of Guangxi Young Qihuang Scholar
  • Young Elite Scientists Sponsorship Program
  • Guangxi Science and Technology Base and Talent Project
  • Guangxi Natural Science FoundationYouth Fund Project
  • Doctoral Foundation of Guangxi University of Chinese Medicine
  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China
  • Innovation Project of Guangxi Graduate Education

Zitieren

APA

Liao, L., Liu, L., Zou, X., Shen, P., Zhao, J., Wang, J., Shen, Y., Xiao, L., Yuan, R., & Gao, H. (2026). Platycodin D Attenuates Lipopolysaccharide‐Induced Acute Lung Injury by Modulating CD14 ‐Associated Inflammatory Signaling and Macrophage Phenotypic Responses. Phytotherapy Research. https://doi.org/10.1002/ptr.70523

Vancouver

Liao L, Liu L, Zou X, Shen P, Zhao J, Wang J, et al. Platycodin D Attenuates Lipopolysaccharide‐Induced Acute Lung Injury by Modulating CD14 ‐Associated Inflammatory Signaling and Macrophage Phenotypic Responses. Phytotherapy Research. 2026. doi:10.1002/ptr.70523

BibTeX
@article{Liao2026,
  author = {Liao, Lianting and Liu, Lina and Zou, Xianmin and Shen, Pengfei and Zhao, Jinlong and Wang, Junhao and Shen, Yufang and Xiao, Linyu and Yuan, Renyikun and Gao, Hongwei},
  title = {Platycodin D Attenuates Lipopolysaccharide‐Induced Acute Lung Injury by Modulating CD14 ‐Associated Inflammatory Signaling and Macrophage Phenotypic Responses},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70523}
}
Kostenlos starten →